Hemagglutination Inhibition Antibody Titers as a Correlate of Protection Against Seasonal A/H3N2 Influenza Disease

Background.  To investigate the relationship between hemagglutinin-inhibition (HI) antibody levels to the risk of influenza disease, we conducted a correlate of protection analysis using pooled data from previously published randomized trials. Methods.  Data on the occurrence of laboratory-confirmed...

Full description

Saved in:
Bibliographic Details
Published inOpen forum infectious diseases Vol. 2; no. 2; p. ofv067
Main Authors Benoit, Anne, Beran, Jiri, Devaster, Jeanne-Marie, Esen, Meral, Launay, Odile, Leroux-Roels, Geert, McElhaney, Janet E., Oostvogels, Lidia, van Essen, Gerrit A., Gaglani, Manjusha, Jackson, Lisa A., Vesikari, Timo, Legrand, Catherine, Tibaldi, Fabian, Innis, Bruce L., Dewé, Walthère
Format Journal Article
LanguageEnglish
Published United States Oxford University Press 01.04.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background.  To investigate the relationship between hemagglutinin-inhibition (HI) antibody levels to the risk of influenza disease, we conducted a correlate of protection analysis using pooled data from previously published randomized trials. Methods.  Data on the occurrence of laboratory-confirmed influenza and HI levels pre- and postvaccination were analyzed from 4 datasets: 3 datasets included subjects aged <65 years who received inactivated trivalent influenza vaccine (TIV) or placebo, and 1 dataset included subjects aged ≥65 years who received AS03-adjuvanted TIV (AS03-TIV) or TIV. A logistic model was used to evaluate the relationship between the postvaccination titer of A/H3N2 HI antibodies and occurrence of A/H3N2 disease. We then built a receiver-operating characteristic curve to ide.jpegy a potential cutoff titer between protection and no protection. Results.  The baseline odds ratio of A/H3N2 disease was higher for subjects aged ≥65 years than <65 years and higher in seasons of strong epidemic intensity than moderate or low intensity. Including age and epidemic intensity as covariates, a 4-fold increase in titer was associated with a 2-fold decrease in the risk of A/H3N2 disease. Conclusions.  The modeling exercise confirmed a relationship between A/H3N2 disease and HI responses, but it did not allow an evaluation of the predictive power of the HI response.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Present Affiliation: GSK Vaccines, Rixensart, Belgium.
ISSN:2328-8957
2328-8957
DOI:10.1093/ofid/ofv067